Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo

Current Biology

Volumn 8, Issue 3, 1998, Pages 125-135

  Hartmann, Guido ^a,c   Prospero, Terence ^a   Brinkmann, Volker ^b   Ozcelik, Öemil ^b   Winter, Greg ^a   Hepple, Jonathan ^a   Batley, Sarah ^a   Bladt, Friedhelm ^b   Sachs, Martin ^b   Birchmeier, Carmen ^b   Birchmeier, Walter ^b   Gherardi, Ermanno ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 13144295030     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(98)70059-4     Document Type: Article

References (51)

1. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61:203-212.
2. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to Its high affinity receptor. Cell 1991, 64:841-848.
3. Rapraeger AC, Krufka A, Olwin BB: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705-1708.
4. Johnson GR, Wong L: Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J Biol Chem 1994, 269:27149-27154.
5. Higashiyama S, Abraham JA, Klagsbrun M: Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol 1993, 122:933-940.
6. 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 1995, 270:11322-11326.
7. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327:239-242.
8. Gherardi E, Gray J, Stoker M, Perryman M, Furlong R: Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interaction and movement. Proc Natl Acad Sci USA 1989, 86:5844-5848.
9. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T: Purification and subunit structure of hepatocyte growth factor from rat platelets. Fed Eur Biochem Soc Lett 1987, 224:311-316.
10. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al.: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443.
11. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, et al.: Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989, 163:967-973.
12. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, et al.: Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991, 88:7001-7005.
13. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N: Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993, 268:10024-10028.
14. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, et al.: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992, 11:4825-4833.
15. Mars WM, Zarnegar R, Michalopoulos GK: Activation of hepatocyte growth factor by the plasminogen activators and tPA. Am J Pathol 1993, 143:949-958.
16. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, et al.: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991, 251:802-804.
17. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, et al.: Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991, 10:2867-2878.
18. Arakaki N, Hirono S, Ishii T, Kimoto M, Kawakami S, Nakayama H, et al.: Identification and partial characterization of two classes of receptors for human hepatocyte growth factor on adult rat hepatocytes in primary culture. J Biol Chem 1992, 267:7101-7107.
19. Komada M, Miyazawa K, Kitamura N: Characterization of hepatocyte-growth-factor receptors on Meth A cells. Eur J Biochem 1992, 204:857-864.
20. Rosen EM, Goldberg ID, Kacinski BM, Buckholz T, Vinter DW: Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol 1989, 25:163-73.
21. Weidner MK, Behrens J, Vandekerckhove J, Birchmeyer W: Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990, 111:2097-2108.
22. Zioncheck TF, Richardson L, Liu J, Chang L, King KL, Bennett GL, et al: Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J Biol Chem 1995, 270:16871-16878.
23. Kato Y, Liu K-X, Nakamura T, Sugiyama Y: Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity. Hepatology 1994, 20:417-424.
24. Mizuno K, Inoue H, Hagiya M, Shimizu S, Nose T, Shimohigashi Y, et al.: Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem 1994, 269:1131-1136.
25. Matsumoto K, Takehara T, Inoue H, Hagiya M, Shimizu S, Nakamura T: Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities. Biochem Biophys Res Commun 1991, 181:691-699.
26. Hartmann G, Naldini L, Weidner KM, Sachs M, Vigna E, Comoglio PM, et al.: A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci USA 1992, 89:11574-11578.
27. Lokker NA, Mark MR, Luis EA, Bennett GL, Robbins KA, Baker JB, et al.: Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J 1992, 11:2503-2510.
28. Okigaki M, Komada M, Uehara Y, Miyazawa K, Kitamura N: Functional characterization of human hepatocyte growth factor mutants obtained by deletion of structural domains. Biochemistry 1992, 31:9555-9561.
29. Donate L, Gherardi E, Srinivasan N, Sowdhamini R, Aparicio S, Blundell T: Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci 1994, 3:2378-2394.
30. Carrell RW, Stein PE, Fermi G, Wardell MR: Biological implications of a 3 structure of dimeric antithrombin. Structure 1994, 2:257-270.
31. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC: Heparin structure and interactions with basic fibroblast growth factor. Science 1996, 271:1116-1120.
32. Wiman B: Primary structure of peptides released during activation of human plasminogen by urokinase. Eur J Biochem 1973, 39:1-9.
33. Schwall RH, Chang LY, Godowskj PJ, Kahn DW, Hillan KJ, Bauer KD, et al.: Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J Cell Biol 1996, 133:709-718.
34. Appasamy R, Tanabe M, Murase N, Zarnegar R, Venkataramanan R, Vanthiel DH, et al.: Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest 1993, 68:270-276.
35. Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SE, Godowski PJ: The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous adminstration in rats. Endocrinology 1994, 134:1879-1887.
36. Lokker NA, Presta LG, Godowski PJ: Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor. Protein Eng 1994, 7:895-903.
37. Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, et al.: Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. J Biol Chem 1997, 272:9457-9463.
38. Schreiber G, Fersht AR: Rapid, electrostatically assisted association of proteins. Nature Struct Biol 1996, 3:427-431.
39. Mach H, Volkin DB, Burke CJ, Middaugh CR, Linhardt RJ, Fromm JR, et al.: Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry 1993, 32:5480-5489.
40. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT: Interaction of hepatocyte growth factor with heparan sulfate. J Biol Chem 1994, 269:11216-11223.
41. Pantoliano MW, Horlick RA, Springer BA, Van Dyk DE, Tobery T, Wetmore DR, et al.: Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994, 33:10229-10248.
42. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, et al.: Heparin-Induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994, 79:1015-1024.
43. Wolpert L: Positional information revisited. Development 1989, 107(Supp):3-12.
44. Gurdon JB, Mitchell A, Mahony D: Direct and continuous assessment by cells of their position in a morphogen gradient. Nature 1995, 376:520-521.
45. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C: Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995, 376:768-771.
46. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, et al.: Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993, 18:1443-1449.
47. Kawaida K, Matsumoto K, Shimazu H, Nakamura T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994, 91:4357-4362.
48. Roos F, Ryan AM, Chamow SM, Bennett GL, Schwall RH: Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor. Am J Physiol 1995, 268:G380-G386.
49. Frixen U, Behrens J, Sachs M, Ebeirle G, Voss B, Warda A, et al.: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991, 113:173-185.
50. Scorer CA, Clare JJ, McCombie WR, Romanos MA, Sreekrishna K: Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Bio/Technology 1994, 12:181-184.
51. O' Shannessy DJ, Brigham-Burke M, Soneson KK, Hensley P, Brooks I: Determination of rate and equilibrium binding constants for macromolecular interactions by surface plasmon resonance. Meth Enzymol 1994, 240:323-349.